Chad Winters - 18 Feb 2025 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP, Chief Accounting Officer
Signature
/s/ Louis Lalli, as an agent for Chad Winters
Issuer symbol
WST
Transactions as of
18 Feb 2025
Net transactions value
+$11,463
Form type
4
Filing time
20 Feb 2025, 21:09:48 UTC
Previous filing
12 Mar 2024
Next filing
19 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $17,313 +82 +6.3% $211.00 1,391 18 Feb 2025 Direct
transaction WST Common Stock Tax liability $5,850 -28 -2% $211.00 1,363 18 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Option (Right to Buy) Award $0 +822 $0.000000 822 18 Feb 2025 Common Stock 822 $211.00 Direct F1
transaction WST Rst. Stock Unit Award $0 +356 $0.000000 356 18 Feb 2025 Common Stock 356 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in four equal installments beginning on February 18, 2026.